Petros Pharmaceuticals (PTPI) Financial Statements
Petros Pharmaceuticals Financial Overview
Petros Pharmaceuticals's market cap is currently $84.75K. The company's EPS TTM is $8.51; its P/E ratio is 0.00; Petros Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 5.11M | $ 5.82M | $ 5.99M | $ 7.81M |
| Gross Profit | $ 0.00 | $ 3.90M | $ 4.19M | $ 3.70M | $ 6.21M |
| Operating Income | $ -4.64M | $ -17.68M | $ -13.62M | $ -19.92M | $ -18.05M |
| EBITDA | $ -4.50M | $ -10.81M | $ -4.21M | $ -13.73M | $ -1.74M |
| Net Income | $ 1.91M | $ -14.32M | $ -8.16M | $ -20.04M | $ -8.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.14M | $ 3.71M | $ 13.34M | $ 9.43M | $ 23.85M |
| Total Assets | $ 5.16M | $ 10.64M | $ 33.80M | $ 32.42M | $ 67.39M |
| Total Debt | $ 0.00 | $ 7.39M | $ 8.28M | $ 9.88M | $ 405.02K |
| Net Debt | $ -5.14M | $ 3.68M | $ -5.06M | $ 456.53K | $ -23.44M |
| Total Liabilities | $ 2.29M | $ 18.10M | $ 21.32M | $ 15.72M | $ 31.85M |
| Stockholders' Equity | $ 2.87M | $ -7.47M | $ 12.48M | $ 16.70M | $ 35.54M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.73M | $ -2.63M | $ -7.63M | $ -12.80M | $ -11.86M |
| Operating Cash Flow | $ -6.73M | $ -2.60M | $ -7.63M | $ -12.80M | $ -11.86M |
| Investing Cash Flow | $ 0.00 | $ -24.59K | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 8.16M | $ -7.00M | $ 11.54M | $ -1.62M | $ 18.57M |
Currency in USD